{"id":371931,"date":"2022-05-04T15:30:00","date_gmt":"2022-05-04T13:30:00","guid":{"rendered":"https:\/\/innovationorigins.com\/?post_type=selected&amp;p=371931"},"modified":"2022-05-04T15:30:00","modified_gmt":"2022-05-04T13:30:00","slug":"breakthrough-in-the-treatment-of-dupuytren-disease","status":"publish","type":"selected","link":"https:\/\/ioplus.nl\/archive\/en\/selected\/breakthrough-in-the-treatment-of-dupuytren-disease\/","title":{"rendered":"Breakthrough in the treatment of Dupuytren disease"},"content":{"rendered":"\n<p>Researchers at the\u00a0<a href=\"https:\/\/www.kennedy.ox.ac.uk\/\">Kennedy Institute<\/a>, University of Oxford, led by\u00a0<a href=\"https:\/\/www.kennedy.ox.ac.uk\/team\/jagdeep-nanchahal\">Professor Jagdeep Nanchahal<\/a>\u00a0have demonstrated the efficacy of the anti-TNF drug adalimumab for patients with early stage Dupuytren\u2019s disease, writes the English university in this <a href=\"https:\/\/www.ox.ac.uk\/news\/2022-05-03-breakthrough-treatment-dupuytren-s-disease\">press release<\/a>.<\/p>\n\n\n\n<p>&#8216;This phase 2b trial represents the clinical translation of our\u00a0<a href=\"https:\/\/www.pnas.org\/doi\/full\/10.1073\/pnas.1301100110\">laboratory findings<\/a>, where we<a href=\"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aay0370\">\u00a0identified TNF as a potential therapeutic target<\/a>\u00a0followed by a\u00a0<a href=\"https:\/\/www.thelancet.com\/journals\/ebiom\/article\/PIIS2352-3964(18)30229-9\/fulltext\">phase 2a dose ranging trial<\/a>\u00a0which showed that the highly concentrated formulation injected directly into the diseased tissues was effective in downregulating myofibroblasts, the cells responsible for fibrosis,&#8217; said Jagdeep Nanchahal, Oxford Professor of Hand, Plastic and Reconstructive Surgery. &#8216;We also found the treatment to be completely safe and there were no related serious adverse events.&#8217;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">No treatment before<\/h3>\n\n\n\n<p>Dupuytren\u2019s disease is a common condition of the hand that affects about 5 percent of the UK population and tends to run in families. It causes the fingers to curl irreversibly into the palm and can be extremely disabling. There is currently no treatment for early disease and typically people have to wait until the condition deteriorates when surgery can be performed.<\/p>\n\n\n\n<p>The trial recruited 140 participants with early-stage Dupuytren\u2019s disease who were randomised to receive 4 injections at 3 monthly intervals of either adalimumab (40mg adalimumab in 0.4ml) or saline. The primary outcome was nodule hardness measured at 12 months, and patients were followed up for a total of 18 months.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Adalimubad is effective <\/h3>\n\n\n\n<p>Published in&nbsp;<a href=\"https:\/\/doi.org\/10.1016\/%20S2665-9913(22)00093-5\"><em>The Lancet Rheumatology<\/em><\/a>, the study found that the patients receiving adalimumab experienced softening and reduction in size of the treated nodule. Although adalimumab only has a half-life of about two or three weeks the researchers saw continued effects nine months after the last injection, indicating a sustained treatment effect.<\/p>\n\n\n\n<p>&#8216;This could be a game-changer for patients who suffer from this disabling condition,&#8217; said\u00a0<a href=\"https:\/\/www.kennedy.ox.ac.uk\/team\/christopher-buckley\">Professor Chris Buckley<\/a>, Director of Clinical Research at the Kennedy Institute. &#8216;Dupuytren\u2019s disease is easy to spot at an early stage, so by starting a course of anti-TNF injections could bring long lasting respite and prevent the disease advancing to the stage that surgery is needed.&#8217; <\/p>\n\n\n<div class=\"vlp-link-container vlp-layout-basic wp-block-visual-link-preview-link\"><a href=\"https:\/\/ioplus.nl\/archive\/en\/tarsier-pharma-combats-blindness-caused-by-disease-in-a-modern-way\/\" class=\"vlp-link\" title=\"Tarsier\u2122 Pharma combats blindness caused by disease in a modern way\"><\/a><div class=\"vlp-layout-zone-side\"><div class=\"vlp-block-2 vlp-link-image\"><\/div><\/div><div class=\"vlp-layout-zone-main\"><div class=\"vlp-block-0 vlp-link-title\">Tarsier\u2122 Pharma combats blindness caused by disease in a modern way<\/div><div class=\"vlp-block-1 vlp-link-summary\">Diseases that can cause loss of vision or blindness can rarely be fought without risk. <\/div><\/div><\/div>","protected":false},"author":2084,"featured_media":511434,"template":"","meta":{"_acf_changed":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":""},"categories":[34665],"tags":[127574,127576,4647,30662,48840],"location":[],"internal_archives":[],"class_list":["post-371931","selected","type-selected","status-publish","has-post-thumbnail","hentry","category-health","tag-disease-treatment","tag-dupuytren-disease","tag-health-en","tag-therapy","tag-university-of-oxford"],"blocksy_meta":[],"acf":[],"featured_img":"https:\/\/ioplus.nl\/archive\/wp-content\/uploads\/2022\/01\/dSxm4oZI-oog.jpeg","coauthors":[],"author_meta":{"author_link":"https:\/\/ioplus.nl\/archive\/author\/mauro-mereu\/","display_name":"Mauro Mereu"},"relative_dates":{"created":"Posted 4 years ago","modified":"Updated 4 years ago"},"absolute_dates":{"created":"Posted on May 4, 2022","modified":"Updated on May 4, 2022"},"absolute_dates_time":{"created":"Posted on May 4, 2022 3:30 pm","modified":"Updated on May 4, 2022 3:30 pm"},"featured_img_caption":"","tax_additional":{"category":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/health\/\" class=\"advgb-post-tax-term\">Health<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Health<\/span>"],"slug":"category","name":"Categories"},"post_tag":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/en\/tag\/disease-treatment\/\" class=\"advgb-post-tax-term\">disease treatment<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/tag\/dupuytren-disease\/\" class=\"advgb-post-tax-term\">Dupuytren disease<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/tag\/health-en\/\" class=\"advgb-post-tax-term\">health<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/tag\/therapy\/\" class=\"advgb-post-tax-term\">therapy<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/tag\/university-of-oxford\/\" class=\"advgb-post-tax-term\">University of Oxford<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">disease treatment<\/span>","<span class=\"advgb-post-tax-term\">Dupuytren disease<\/span>","<span class=\"advgb-post-tax-term\">health<\/span>","<span class=\"advgb-post-tax-term\">therapy<\/span>","<span class=\"advgb-post-tax-term\">University of Oxford<\/span>"],"slug":"post_tag","name":"Tags"},"language":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/en\/\" class=\"advgb-post-tax-term\">EN<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">EN<\/span>"],"slug":"language","name":"Tags"},"post_translations":{"linked":[],"unlinked":[],"slug":"post_translations","name":""},"location":{"linked":[],"unlinked":[],"slug":"location","name":"Locations"},"internal_archives":{"linked":[],"unlinked":[],"slug":"internal_archives","name":"Internal Archives"}},"series_order":"","_links":{"self":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/selected\/371931","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/selected"}],"about":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/types\/selected"}],"author":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/users\/2084"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media\/511434"}],"wp:attachment":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media?parent=371931"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/categories?post=371931"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/tags?post=371931"},{"taxonomy":"location","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/location?post=371931"},{"taxonomy":"internal_archives","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/internal_archives?post=371931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}